UNSPSC 51373449: Codeine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373449 Codeine/phenylephrine/phenylpropanolamine is a Commodity code that in practice captures state and local procurement of naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products distributed across government health and human services facilities. The code sees activity from county health departments, state procurement offices administering cooperative purchasing vehicles, and multistate purchasing alliances. Work under this code ranges from direct acquisition of emergency medical countermeasures (naloxone kits and drug disposal systems) to bulk supply agreements for generic pharmaceuticals and OTC products through authorized wholesalers, with vendors expected to meet FDA compliance, cGMP certification, Drug Supply Chain Security Act requirements, and specific insurance minimums including general liability and professional liability coverage.

Recent activity spans Florida and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, response deadline July 26, 2023. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 to establish multiple-award contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. MMCAP requires vendors to maintain relationships with authorized wholesalers AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and pricing is weighted 75 percent of the evaluation score, with a 3 percent administrative fee applied to all purchases.